Results

Total Results: 1,187 records

Showing results for "week".

61. Cer-250-Cannabis-2025-Surv-Rep-Update-Tables-E1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
    January 01, 2025 - , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period Endpoint dose … of 1 mg per day 4 weeks of placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of … placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for three weeks NA NA 4 Short … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of

62. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period Endpoint dose … of 1 mg per day 4 weeks of placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of … placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for three weeks NA NA 4 Short … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of

63. Cannabis-2023-Surv-Rep-1-App-F (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period Endpoint dose … of 1 mg per day 4 weeks of placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of … placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for three weeks NA NA 4 Short … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of

64. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period Endpoint dose … of 1 mg per day 4 weeks of placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of … placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for three weeks NA NA 4 Short … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of

65. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period Endpoint dose … of 1 mg per day 4 weeks of placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of … placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for three weeks NA NA 4 Short … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of

66. App-E-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

67. Alcohol-Misuse Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
    April 28, 2010 - thresholds.21 Maximum recommended consumption is three or fewer standard drinks per day (seven per week … women and for anyone older than 65 years of age, and four or fewer standard drinks per day (14 per week … , grams of alcohol per week), heavy drinking episodes, achieving recommended drinking limits, receipt … in drinks per week was not statistically significant for that study (WMD, -0.2, 95% CI, -8.9 to … We found an average reduction of 3.6 drinks per week for adults receiving interventions compared with

68. Methods Research Report: Creating Efficiencies in the Extraction of Data From Randomized Trials (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
    August 01, 2021 - conventional HD for four hours per treatment (12 hours total per week, control) followed by 5 days … per week short, more frequent HD for two hours and 25 minutes per treatment (12 hours total per week … and averaged prior to each HD session, three days per week, regardless of which treatment frequency … , 5 days per week in-center hemodialysis versus 3 days per week treatment: a randomized cross-over pilot … Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized

69. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period Endpoint dose … of 1 mg per day 4 weeks of placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of … placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for three weeks NA NA 4 Short … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of

70. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period Endpoint dose … of 1 mg per day 4 weeks of placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of … placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for three weeks NA NA 4 Short … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of

71. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
    January 01, 2022 - , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period Endpoint dose … of 1 mg per day 4 weeks of placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of … placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for three weeks NA NA 4 Short … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of

72. Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
    March 01, 2018 - For the 13-week followup after randomization, CT.gov reported only final values, but the publication … By searching ClinicalTrials.gov, we identified one unpublished, 12-week study with 369 participants … This small (N = 81), 24-week study could add to the body of evidence once it is completed. … This small (N = 81), 24-week study could add to the body of evidence once it is completed. 45 … Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.

73. Infectious Disease Including HIV/AIDS #09 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
    December 01, 2015 - The cost of a 4-week supply of generic RBV (1,000 mg) is about $400. … The cost of a 4-week supply of IFN is about $3,500. … Post-treatment HCV relapse occurred in 1% to 2% of patients in the 12-week treatment groups and 20% … -based, online aggregator of prescription-drug prices, GoodRx, the retail cost of a 4-week supply of … All-oral 12-week combination treatment with daclatasvir (DCV) and sofosbuvir (SOF) in treatment-

74. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
    October 18, 2010 - Preterm birth is defined as delivery before the completion of the 37th week of gestation and affects … available during select hours of the day only Telephone support available 24 hours a day, 7 days a week

75. Appendix-E-Evidence-Tables-E1-E4 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
    May 29, 2025 - , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period Endpoint dose … of 1 mg per day 4 weeks of placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for … , then 1 mg for 3 weeks, then a 1 week washout period followed by a 4 week placebo period 4 weeks of … placebo, 1 week washout period, Nabilone 0.5 mg for one week, then 1 mg for three weeks NA NA 4 Short … a 1 week washout period followed by a 4 week placebo period 4 weeks of placebo, 1 week washout period

76. Infectious Disease Including HIV/AIDS #09 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
    December 22, 2014 - The cost of a 4- week supply of generic RBV (1,000 mg) is about $300. … The cost of a 4-week supply of IFN is about $3,300. … -based, online aggregator of prescription- drug prices, GoodRx, the retail cost of a 4-week supply of … sofosbuvir is roughly $29,500 ($88,500 for a standard 12-week course).39 The total cost of 12 weeks … would be required to treat HCV genotype 1 or 4 infection, is about $99,300.39-41 The cost of a 12-week

77. App-E-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

78. App-E-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

79. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pregnancy_hi_impact.pdf
    January 01, 2012 - utero) or chorionic villus sampling (harvesting placental tissue cells in utero), depending on the week … by week,” which is a Web-based information venue requiring fast Internet connectivity. … Available: http://www.mayoclinic.com/health/pregnancy- week-by-week/MY00331. 11. Pregnancy. … prenatalcare.html http://www.nlm.nih.gov/medlineplus/prenatalcare.html http://www.mayoclinic.com/health/pregnancy-week-by-week … /MY00331 http://www.mayoclinic.com/health/pregnancy-week-by-week/MY00331 http://www.marchofdimes.com/

80. Restless-Legs Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - Trials were short (one crossover trial of two 4-week intervals,46 three 6-week trials,43-45 and three … 12-week trials.40-42 The mean age of study participants was 51 years. … Comparative Harms One small moderate-quality crossover trial (n=39)16 of two 4-week periods reported … TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. … A 52-week study of gabapentin enacarbil in restless legs syndrome.